Study Group: Experts on Pay-for-Performance Plans(?)
Council Members in this Study Group: 163
Request a survey with this Study Group
Leading Experts in this Study Group
Independent Contractor
Independent Contractor - Arnold Greensher
Arnold Greensher, MD, is a Medical Director for the commercial managed care section of Schaller Anderson Healthcare, Arizona. He is Board certified in Family Practice and Pediatrics and fellowship trained in Genetics. Dr. Greensher lectures widely on issues related to Medical Malpractice, Risk Management...
Frederic GoldsteinPresident and Chief Operating Officer
U.S. Preventive Medicine, Inc.
Frederic Goldstein, MS, is the President and Chief Operating Officer of U.S. Preventive Medicine, Inc. Mr. Goldstein joined USPM when Specialty Disease Management Services, Inc. which he founded and served as President was acquired by USPM in October of 2007. Mr. Goldstein has expertise in disease management,...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Medicare Experts | 429 |
| Managed Care Experts | 559 |
| Economic Experts on Managed Care | 630 |
| Managed Care Pricing Trends Experts | 219 |
| Formulary Design Experts | 168 |
| Generic Drug Economic Experts | 635 |
| Pharmacists (US) | 2080 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Healthways reported lower than expected earnings in its current quarter and analysts are pointing to a tightening in the healthcare markets and the fact that Healthways products are expensive. Does this really make sense?
Misaligned economic incentives are mostly responsible for the low rates of adoption of EHRs. Physician resistance to change is much less a force than the simple fact that it costs time and money to convert a practice to an EHR, and the financial benefits of an EHR do not accrue to the physici...
Calling a 0.89% improvement "significant" just seems to me to show the weakness of this current trial. Anyone can use statistics to prove just about anything. Using verbal manipulation to puff up a study's result is unfair, unreliable and just plain sad.
When the new administration come in, medicine and big pharma are both going to be hit hard. Industry sponsored research is going to be examined with a fine tooth comb. All we need is another scandal. It's getting harder and harder to trust industry sponsored research, with news coming...
The passage of this bill by the Senate and the likely passage by the house are both good for consumers as well as the companies that conduct genetic testing.
Most Common Company Types:
- Managed Care Health Insurer, For-Profit
- Office Based Private Practice or Clinic
- Managed Care Health Insurer, Non-Profit
- Blue Cross/Blue Shield Non-Profit Health Insurer
- Academic Medical Center/Hospital or Clinic
- Other Health Insurer, For-Profit
- Consultancy, Healthcare-Focused
- Third Party Administrator
Most Common Job Types:
- Director
- Medical Director
- Physician - Attending Physician
- President
- Pharmacist - RPh/PharmD
- Owner
- Chief Medical Officer
- Manager
- Chief Executive Officer
- Chief Financial Officer
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms